VistaGen Therapeutics logo
VistaGen Therapeutics VTGN
$ 3.08 -0.32%

Quarterly report 2024-Q2
added 08-13-2024

report update icon

VistaGen Therapeutics Depreciation & Amortization 2011-2024 | VTGN

Annual Depreciation & Amortization VistaGen Therapeutics

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
127 K 130 K 154 K 118 K 103 K 91.2 K 80.7 K 54.9 K 53.5 K 59.1 K 54.6 K 33.8 K 45.6 K 45.3 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
154 K 33.8 K 82.1 K

Quarterly Depreciation & Amortization VistaGen Therapeutics

2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
34 K - - 32 K - 30.6 K 96.2 K 32.3 K - 43.7 K 115 K 71.2 K - 26.4 K 25.5 K 25.4 K - 25.5 K 77.6 K 52.1 K 26.2 K - 64.8 K 37.9 K - - - 23.6 K - - 37.6 K 26 K - - 40.8 K 28.9 K - - 39.2 K 26.2 K - - 40.2 K 25.8 K - - 21 K 11.8 K - - 33.5 K 21.3 K -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
115 K 11.8 K 39.7 K